Phytomedicine
Volume 16, Issue 1 , Pages 56-64, January 2009

A pharmaceutical preparation of Salvia miltiorrhiza protects cardiac myocytes from tumor necrosis factor-induced apoptosis and reduces angiotensin II-stimulated collagen synthesis in fibroblasts

  • Shanhong Ling

      Affiliations

    • Department of Medicine, Monash University Central and Eastern Clinical School, Alfred Hospital, Commercial Road, Prahran, Melbourne, Victoria 3181, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61399030615; fax: +61399030018.
  • ,
  • Ruizhi Luo

      Affiliations

    • Institute of Research and Development (R&D), Tasly Pharmaceutical Co., LTD, Tianjin 300402, China
  • ,
  • Aozhi Dai

      Affiliations

    • Department of Medicine, Monash University Central and Eastern Clinical School, Alfred Hospital, Commercial Road, Prahran, Melbourne, Victoria 3181, Australia
  • ,
  • Zhixin Guo

      Affiliations

    • Institute of Research and Development (R&D), Tasly Pharmaceutical Co., LTD, Tianjin 300402, China
  • ,
  • Ruoling Guo

      Affiliations

    • Institute of Research and Development (R&D), Tasly Pharmaceutical Co., LTD, Tianjin 300402, China
  • ,
  • Paul A. Komesaroff

      Affiliations

    • Department of Medicine, Monash University Central and Eastern Clinical School, Alfred Hospital, Commercial Road, Prahran, Melbourne, Victoria 3181, Australia

Abstract 

Salvia miltiorrhiza is a medicinal herb commonly used in traditional Chinese medicine for the prevention and treatment of cardiovascular disease. This study investigated the effects of Cardiotonic Pill (CP), a pharmaceutical preparation of Salvia miltiorrhiza, on cardiac myocytes and fibroblasts with respect to the viability, proliferation, and collagen synthesis in these cells under various conditions. A cardiac myocyte line, H9c2, and primarily cultured fibroblasts from rat hearts were incubated with CP over a broad concentration range (50–800μg/ml) under normal cultures, conditions of ischemia (serum-free culture), and stimulation by angiotensin II (AII, 100nM), hydrogen peroxide (H2O2, 50–200μM), or tumor necrosis factor α (TNFα, 40ng/ml) for 24–48h. Cell growth, apoptosis, DNA and collagen synthesis, and expression of relevant genes were assessed via cell number study, morphological examination, Annexin-V staining, flow-cytometry, [3H]-thymidine or [3H]-proline incorporation assay, and Western blotting analysis. It was found that (1) at therapeutic (50μg/ml) and double therapeutic (100μg/ml) concentrations, CP did not significantly affect normal DNA synthesis and cell growth in these cardiac cells, while at higher (over 4-fold therapeutic) concentrations (200–800μg/ml), CP decreased DNA synthesis and cell growth and increased cell death; (2) CP treatment (50μg/ml) significantly inhibited TNFα-induced apoptosis in myocytes, with 12.3±1.46% cells being apoptosis in CP treatment group and 37.0±7.34% in the control (p<0.01), and simultaneously, expression of activated (phosphorylated) Akt protein was increased by about 2 folds in the CP-treated cells; and (3) in cultured fibroblasts, CP significantly reduced AII-induced collagen synthesis in a concentration-dependent manner (by ∼50% and ∼90% reduction of AII-induced collagen synthesis at 50 and 100μg/ml, respectively). Thus, Salvia miltiorrhiza preparation CP is physiologically active on cardiac cells. The actions by CP to reduce apoptotic damage in myocytes and collagen synthesis in fibroblasts may help to preserve the heart function and reduce heart failure risk. The actions by CP to inhibit DNA synthesis and cell growth, which occurred at over therapeutic doses, may weaken the ability of heart repair. Further studies are needed to identify the chemical compounds in this herbal product that are responsible for these observed physiological effects.

Keywords: Apoptosis, Cardiac myocytes, Collagen synthesis, Fibroblasts, Growth, Salvia miltiorrhiza

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0944-7113(08)00172-4

doi:10.1016/j.phymed.2008.09.008

Phytomedicine
Volume 16, Issue 1 , Pages 56-64, January 2009